Charles Schwab Investment Management Inc. lifted its position in shares of The Joint Corp. (NASDAQ:JYNT – Free Report) by 9.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 36,204 shares of the company’s stock after acquiring an additional 3,029 shares during the period. Charles Schwab Investment Management Inc. owned 0.24% of Joint worth $385,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of the company. FMR LLC grew its position in Joint by 38.0% in the 3rd quarter. FMR LLC now owns 10,787 shares of the company’s stock worth $123,000 after purchasing an additional 2,971 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Joint by 5.4% during the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock worth $258,000 after buying an additional 1,156 shares during the period. O Brien Greene & Co. Inc grew its holdings in Joint by 3.5% in the 3rd quarter. O Brien Greene & Co. Inc now owns 119,620 shares of the company’s stock worth $1,368,000 after buying an additional 4,000 shares in the last quarter. Barclays PLC increased its position in Joint by 71.4% in the 3rd quarter. Barclays PLC now owns 25,609 shares of the company’s stock valued at $294,000 after acquiring an additional 10,671 shares during the period. Finally, Geode Capital Management LLC raised its stake in Joint by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 291,581 shares of the company’s stock valued at $3,336,000 after acquiring an additional 3,043 shares in the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.
Analyst Ratings Changes
Separately, StockNews.com lowered Joint from a “buy” rating to a “hold” rating in a research report on Monday, March 17th.
Joint Trading Down 1.3 %
Joint stock opened at $12.49 on Tuesday. The company’s 50-day moving average price is $11.50 and its two-hundred day moving average price is $11.24. The stock has a market cap of $189.54 million, a price-to-earnings ratio of -10.96 and a beta of 1.61. The Joint Corp. has a 52 week low of $9.58 and a 52 week high of $17.82.
Joint Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Stories
- Five stocks we like better than Joint
- What is the Nasdaq? Complete Overview with History
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What Does a Stock Split Mean?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- How to Invest in Small Cap Stocks
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.